Ignite Creation Date:
2025-12-24 @ 3:15 PM
Ignite Modification Date:
2026-01-17 @ 7:12 AM
Study NCT ID:
NCT04625192
Status:
UNKNOWN
Last Update Posted:
2020-11-12
First Post:
2020-11-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trephine Osteotomy in Lateral Sinus Lift
Sponsor:
Hams Hamed Abdelrahman
Organization:
Study Overview
Official Title:
Lateral Sinus Lift Technique Using Trephine Osteotomy With Simultaneous Implant Placement (Clinical Trial)
Status:
UNKNOWN
Status Verified Date:
2020-11
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Trephine osteotomy was used for lateral sinus lifting technique associated with sinus floor augmentation using the autogenous bone resulting from implant drilling using specialized trephine drills.
Detailed Description:
The study includes 14 patients in whom the lateral sinus lift technique was performed using the trephine osteotomy with simultaneous implant placement.
Sinus floor augmentation with autogenous bone graft resulting from implant site preparation with trephine drills.
Implant stability and rate of complications such as Schneiderian membrane perforation and bleeding will be assessed.
Patients will also provide their subjective assessment of postoperative pain and swelling. Vertical bone height, that will be gained, will be assessed radiographically
Sinus floor augmentation with autogenous bone graft resulting from implant site preparation with trephine drills.
Implant stability and rate of complications such as Schneiderian membrane perforation and bleeding will be assessed.
Patients will also provide their subjective assessment of postoperative pain and swelling. Vertical bone height, that will be gained, will be assessed radiographically
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: